Dr. Scott O. Trerotola, MD

Dr. Trerotola practices at Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr) in Philadelphia, Pennsylvania.

Dr. Trerotola's NPI, 1922034438, was assigned on June 25, 2006. Dr. Trerotola graduated from Perelman School of Med at the University of Pennsylvania in 1986. Dr. Trerotola holds Pennsylvania license MD072862L.

Dr. Trerotola's primary practice is Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr), at 3400 Spruce Street, White Bldg 1st Flr, Philadelphia, PA 19104.

Dr. Trerotola's primary practice is Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr) in Philadelphia, Pennsylvania. Dr. Trerotola is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Trerotola to 1 more hospital and 1 medical group, each named with a free account. Dr. Trerotola's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trerotola practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Trerotola's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Trerotola is licensed in Pennsylvania.

CMS data shows 148 Medicare services from Dr. Trerotola across 6 procedure codes in 2024, for 153 Medicare patients. Medicare paid $7,023 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 153 Medicare patients who saw Dr. Trerotola in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 3.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Trerotola's median patient age at 58, with 54% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Trerotola for performance year 2024, reported as part of a group. Dr. Trerotola accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Trerotola to 1 clinical trial. Conditions studied include Arteriovenous Fistula and Vascular Fistula. Open Payments lists research payments to Dr. Trerotola that name 1 trial.

CMS Open Payments shows 285 general payments to Dr. Trerotola from 9 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 81% of the total. Cook Medical LLC paid the most, $978,764. It also lists 5 research payments totaling $44,002 from 2016 to 2017, naming 1 clinical trial.

Dr. Trerotola graduated from Perelman School of Med at the University of Pennsylvania in 1986.